The industry view on long-term toxicology testing in drug development of human pharmaceuticals

Pharmacology and Toxicology, Supplement

Volumn 86, Issue 1, 2000, Pages 1-5

  Van Cauteren, Herman ^a   Bentley, Philip ^a   Bode, Gerd ^c   Cordier, André ^a   Coussement, Werner ^b   Heining, Peter ^a   Sims, Jenny ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

^b Janssen Cilag EMEA Belgium   (Belgium)

^c SANOFI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CONFERENCE PAPER; DRUG DEVELOPMENT; DRUG INDUSTRY; DRUG SAFETY; DRUG SCREENING; FOOD AND DRUG ADMINISTRATION; NONHUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; TOXICITY TESTING;

ANIMALS; DRUG EVALUATION, PRECLINICAL; DRUG INDUSTRY; HUMANS; RODENTIA; TOXICOLOGY; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

RODENTIA;

EID: 0033934754     PISSN: 09019936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (26)

1. Bach, P. H., A. Cockburn, D. J. Esdaile, P. Grasso & C. E. Lumley: Chronic toxicity testing: Present perspectives and the way toward shorter screening, decreased use of resources and better risk assessment. In: Animals and alternatives in toxicology - Present status and future prospects. Eds.: M. Balls, J. Bridges & J. Southee. Mac Millan and Professional, London, England, 1991, pp. 53-89.
2. Betton, G., A. Cockburn, E. Harpur, J. Hopkins, P. Illing, C. Lumley & T. Connors: A critical review of the optimum duration of chronic rodent testing for the determination of non-tumourigenic toxic potential: a report by the BTS working party on duration of toxicity testing. Human & Experimental Toxicol. 1994, 13, 221-232.
3. CMR, Centre for Medicines Research: Assessment of pharmaceuticals for potential human carcinogenic risk. CMR workshop, July 1999. Illustrated Ars Ltd., UK, 1999.
4. Contrera, J. F., D. Aub, E. Barbehenn, E. Belair, C. Chen, G. Evoniuk, K. Mainigi, F. Mielach & L. Sancilio: A retrospective comparison of the results of 6 and 12 month non-rodent toxicity studies. Adverse Drug React. Toxicol. Rev. 1993, 12, 63-76.
5. Contrera, J. F.: Repeated dose toxicity: The FDA data base. In: Proceedings of the First International Conference on Harmonization, Brussels 1991. Eds.: P. F. D'Arcy & D. W. G. Harron. W. & G. Baird Ltd., Northern Ireland, 1992, pp. 245-248.
6. DeGeorge, J.: Carcinogenicity testing: A new approach. In: Proceedings of the Fourth International Conference on Harmonization. Brussels 1997. Eds.: P F. D'Arcy & D. W. G. Harron. W. & G. Baird Ltd., Northern Ireland, 1998, pp. 261-263.
7. Food and Drug Adminsitration, Department of Health and Human Services: International Conference on Harmonisation; Guidance on the duration of chronic toxicity testing in animals (rodent and non-rodent toxicity testing); Availability. Federal Register/ Vol. 64, No. 122/Friday, June 25, 1999/Notices 34259.
8. Griffiths, S.: Company strategies for designing non-clinical safety evaluation programmes: Results from a CMR International Survey. In: Safety evaluation of biotechnologically-derived pharmaceuticals: Facilitating a scientfic approach. Eds.: S. A. Griffith & C. E. Lumley. Kluver Academic Publishers, The Netherlands, 1998, pp. 17-29.
9. Igarashi, T: A review of the Japanese Pharmacutical Manufacturers' association database currently established to examine retrospectively the value of long-term animal toxicity studies. Adverse Drug React. Toxicol. Rev. 1993, 12, 32-52.
10. Igarashi, T: Is the 12-month treatment essential for the repeated dose study. In: Proceedings of the First International Conference on Harmonization, Brussels 1991. Eds.: P. F. D'Arcy & D. W. G. Harron. W. & G. Baird Ltd., Northern Ireland, 1992, pp. 248-253.
11. Lumley, C. E. & S. R. Walker: A critical appraisal of the duration of chronic animal toxicity studies. Reg. Toxicol. Pharmacol. 1986, 6, 66-72.
12. Lumley, C. E. & S. R. Walker: A toxicology databank based on animal safety evaluation studies of pharmaceutical compounds. Human Toxicol. 1985c, 4, 447-460.
13. Lumley, C. E. & S. R. Walker: The establishment of a computer-based toxicology data bank. Medical Informatics 1985b, 10, 173-174.
14. Lumley, C. E. & S. R. Walker: The value of chronic animal toxicology studies of pharmaceutical compounds - A retrospective analysis. Fundam. Appl. Toxicol. 1985a, 5, 1007-1024.
15. Lumley, C. E., C. Parkinson & S. R. Walker: An international Appraisal of the minimum duration of chronic animal toxicity studies. Human & Experimental Toxicol. 1992, 11, 155-162.
16. MacDonald, J. S.: Evaluation of new models. II. In: Proceedings of the Fourth International Conference on Harmonization, Brussels 1997. Eds.: P. F. D'Arcy & D. W. G. Harron. W. & G. Baird Ltd., Northern Ireland, 1998, pp. 272-277.
17. Monroe, A.: Are lifespan rodent carcinogenicity studies defensible for pharmaceutical agents? Exp. Toxic. Pathol. 1996a, 48, 155-166.
18. Monroe, A.: How useful are chronic (life-span) toxicology studies in rodents in identifying pharmaceuticals that pose a carcinogenic risk to humans? Adverse Drug React. Toxicol. Rev. 1993, 12, 5-34.
19. Monroe, A.: Testing for carcinogenic potential. Rapporteur's report. In: Proceedings of the Third Internationa! Conference on Harmonization, Yokohama 1995. Eds.: P. F D'Arcy & D. W. G. Harron. W & G. Baird Ltd., Northern Ireland, 1996b, pp. 261-268.
20. Parkinson, C., C. E. Lumley & S. R. Walker: The value of information generated by long-term toxicity studies in the dog for the nonclinical safety assessment of pharmaceutical compounds. Fundam. Appl. Toxicol. 1995, 25, 115-123.
21. Sjöberg, P.: Maximum duration of non-rodent toxicity studies: Regulatory perspective. In: Proceedings of the Fourth International Conference on Harmonization, Brussels 1997. Eds.: P. F. D'Arcy & D. W. G. Harron. W. & G. Baird Ltd., Northern Ireland, 1998, pp. 289-292.
22. Van Cauteren, H.: New approaches to non-clinical evaluation. In: Proceedings of the Fourth International Conference on Harmonization, Brussels 1997. Eds.: P. F. D'Arcy & D. W. G. Harron. W. & G. Baird Ltd., Northern Ireland, 1998, pp. 496-502.
23. Van Deun, K., H. Van Cauteren, J. Vandenberghe, M. Canning, P. Vanparys & W. Coussement: Review of alternative methods of carcinogenicity testing and evaluation of human pharmaceuticals. Adverse Drug React. Toxicol. Rev. 1997, 16, 215-233.
24. Walker, S.R. & C.E. Lumley: Regulatory requirements for the preclinical safety testing of pharmaceuticals. In: The development of drugs & modern medicines. Eds.: J.W. Gorrad & M. Mitchard. Ellis Horwood, Chichester, England, 1986, pp. 615-626.
25. Worden, A. N. & S. R. Walker: Animal models of long term toxic effects. In: The future of predictive safety evaluation. Eds.: A. N. Worden, D. V. Parke & J. Marks. MTP Press Ltd., Lancaster, England, 1987, pp. 57-64.
26. Zbinden, G.: The concept of multi-species testing in industrial toxicology. Reg. Toxicol Pharmacol. 1993, 17, 85-94.